[1]
|
Anderson, T.J., Grégoire, J., Hegele, R.A., Couture, P., Mancini, G.B., McPherson, R., Francis, G.A., Poirier, P., Lau, D.C., Grover, S., Genest, J., Jr., Carpentier, A.C., Dufour, R., Gupta, M., Ward, R., Leiter, L.A., Lonn, E., Ng, D.S., Pearson, G.J., Yates, G.M., Stone, J.A. and Ur, E. (2013) 2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology, 29, 151-157. http://dx.doi.org/10.1016/j.cjca.2012.11.032
|
[2]
|
Gupta, M., Singh, N., Tsigoulis, M., Kajil, M., Hirjikaka, S., Quan, A., Teoh, H. and Verma, S. (2012) Perceptions of Canadian Primary care physicians towards cardiovascular risk assessment and lipid management. Canadian Journal of Cardiology, 28, 14-19. http://dx.doi.org/10.1016/j.cjca.2011.09.014
|
[3]
|
Conroy, R.M., Pyörälä, K., Fitzgerald, A.P., Sans, S., Menotti, A., De Backer, G., De Bacquer, D., Ducimetière, P., Jousilahti, P., Keil, U., Njølstad, I., Oganov, R.G., Thomsen, T., Tunstall-Pedoe, H., Tverdal, A., Wedel, H., Whincup, P., Wilhelmsen, L. and Graham, I.M. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal, 24, 987-1003. http://dx.doi.org/10.1016/S0195-668X(03)00114-3
|
[4]
|
Ridker, P.M., Danielson, E., Fonseca, F.A., Genest, J., Gotto, A.M., Jr., Kastelein, J.J., Koenig, W., Libby, P., Lorenzatti, A.J., MacFadyen, J.G., Nordestgaard, B.G., Shepherd, J., Willerson, J.T. and Glynn, R.J. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine, 359, 2195. http://dx.doi.org/10.1056/NEJMoa0807646
|
[5]
|
Mosca, L., Barrett-Connor, E. and Wenger, N.K. (2011) Sex/Gender differences in cardiovascular disease prevention what a difference a decade makes. Circulation, 124, 2145-2154. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.968792
|
[6]
|
Linton, M.R.F. and Fazio, S. (2003) A practical approach to risk assessment to prevent coronary artery disease and its complications. American Journal of Cardiology, 92, 19-26. http://dx.doi.org/10.1016/S0002-9149(03)00505-8
|
[7]
|
Armstrong, D.W.J., Brouillard, D. and Matangi, M.F. (2011) The effect of the change in the Framingham risk score calculator between the 2006 and 2009 Canadian lipid guidelines. Canadian Journal of Cardiology, 27, 167-170. http://dx.doi.org/10.1016/j.cjca.2010.12.025
|
[8]
|
Sachdeva, A., Cannon, C.P., Deedwania, P.C., Labresh, K.A., Smith, S.C., Jr., Dai, D., Hernandez, A. and Fonarow, G.C. (2009) Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines. American Heart Journal, 157, 111-117. http://dx.doi.org/10.1016/j.ahj.2008.08.010
|
[9]
|
Biro, S.C., Barber, D.T. and Kotecha, J.A. (2012) Trends in the use of electronic medical records. Canadian Family Physician, 58, e21.
|